Providence Therapeutics

Covid-19 development round-up: February 12, 2021

The state of the hunt:

Russia’s Sputnik V vaccine has reportedly been authorized in 26 countries.
  SAGE recommended that all countries proceed with planned rollouts of the AstraZeneca/Oxford jab, while the Africa CDC offered more cautious guidance, amid reports of low efficacy against viral variants.
  Tanzania has no plans to mount a Covid-19 immunization campaign.

 

Vaccines


Approved or authorized vaccines

SAGE backs AZ jab in all…

Mentions:
Covid-19, vaccines, drugs, WHO, SAGE, AstraZeneca, Oxford University, Africa CDC, SK Bioscience, Pfizer, BioNTech, Sinovac, Butantan Institute, Lekhim, Gamaleya Institute, EMA, CanSino, SII, Moderna, BBIL, J&J, Janssen, CureVac, Takis, Rottapharm Biotech, Razi Vaccine and Serum Research Institute, United Biomedical, Covaxx, ImmunityBio, NantKwest, FDA, Government Pharmaceutical Organization, Mahidol University, PATH, Evonik, IDT Biologika, Biological E, CNBG, Sinopharm, Wockhardt, EC, Providence Therapeutics, UNICEF, COVAX, COVAX AMC, AU, AVATT, Siam Bioscience, Lilly, EUAs, mAbs, Regeneron, Gilead, Roche, ASM, NIH, Synairgen, Corvus Pharmaceuticals, Veru, Eiger BioPharmaceuticals, Ichilov Hospital
Read more
Covid-19 development round-up: January 29, 2021

The state of the hunt:

Novavax’s protein-based vaccine candidate demonstrated 89.3% efficacy in a UK Phase 3 trial.
  J&J/Janssen’s single-dose vaccine was 66% effective against moderate to severe disease in Phase 3.
  Vaccines from J&J, Moderna, Novavax and Pfizer/BioNTech appear less effective against the SARS-CoV-2 variant first identified in South Africa.

 

Vaccines


Approved or authorized vaccines

AstraZeneca/Oxford’s…

Mentions:
Novavax, J&J, Janssen, Moderna, Pfizer, BioNTech, EMA, AstraZeneca, Oxford, SII, WHO, SAGE, Fosun, EU, Gamaleya Institute, CNBG, Sinopharm, Sinovac, BBIL, FDA, Imperial College London, Medigen, Dynavax, Providence Therapeutics, Merck, IAVI, Mass General Brigham, Penn Medicine, BMGF, GI-Cell, IVI, EC, Daiichi Sankyo, JCR Pharmaceuticals, CSL, Sanofi, Novartis, Africa CDC, Lonza, COVAX Facility, Pharmaniaga, Duopharma, AVATT, Valneva, COVAX, UNICEF, CEPI, DP World, FEMA, DoD, CDC, BIBP, Regeneron, Lilly, Vir, GSK, NIH, Zydus Cadila, Rigel Pharmaceuticals, Dr. Reddy’s, Fujifilm, Just-Evotec, Humanigen, BARDA, Emergent, Ajinomoto, Shionogi, Bioage Labs, Pulmotect, Civica Rx
Read more
Covid-19 development round-up: December 11, 2020

The state of the hunt:

Pfizer/BioNTech’s vaccine won U.S. FDA Emergency Use Authorization.
  The inactivated vaccine from CNBG’s Beijing subsidiary secured UAE registration.
  Bharat Biotech and SII requested Indian authorization of their respective jabs.

 

Vaccines


Approved or authorized vaccines
 
The Pfizer/BioNTech vaccine extended its regulatory lead this week with new authorizations, including a U.S. nod.
 
The U.S.…

Mentions:
Covid-19, vaccines, drugs, diagnostics, Pfizer, BioNTech, FDA, CNBG, Sinopharm, BBIL, SII, EMA, WHO, AstraZeneca, Moderna, Gamaleya Institute, Sinovac, Sino Biopharma, J&J, Janssen, Anges, Inovio, Roche, IMBCAS, University of Queensland, CSL, CEPI, Sanofi, GSK, WUSTL, Gennova, Tonix, SK Bioscience, EuBiologics, KMPC, Providence Therapeutics, Health Canada, BioE, OSU, COVAX AMC, Schott Kaisha, SGD Pharma India, Hindustan Syringes, Snowman, Instituto Butantan, Halix, Duke University, RDIF, Shenzhen Kangtai, CureVac, Fareva, ADB, CDC, Dulas, DHL, Amnesty International, Oxfam, People’s Vaccine, Novavax, IAVI, Lilly, Gilead, APEIRON, Cyxone, Sorrento, University of Louisville, AbCellera, Quest Diagnostics, LabCorp, NIH, QIAGEN, Thermo Fisher, BMGF, WTO
Read more
Subscribe to Providence Therapeutics